Abstract
Sepsis is a leading cause of mortality in neutropenic cancer patients. Early initiation of effective causative therapy as well as intensive adjunctive therapy is mandatory to improve outcome. We give recommendations for the management of adults with neutropenia and sepsis. The guidelines are written for clinicians involved in care of cancer patients and focus on pathophysiology, diagnosis and treatment of sepsis during neutropenia.
Publication types
-
Consensus Development Conference
-
Practice Guideline
MeSH terms
-
Adult
-
Anti-Infective Agents / therapeutic use*
-
Anticoagulants / therapeutic use
-
Antineoplastic Agents / adverse effects
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / therapy
-
Disease Management
-
Glucose Metabolism Disorders / etiology
-
Glucose Metabolism Disorders / therapy
-
Humans
-
Neoplasms / complications
-
Neoplasms / drug therapy
-
Neutropenia / chemically induced
-
Neutropenia / complications
-
Neutropenia / therapy*
-
Renal Insufficiency / etiology
-
Renal Insufficiency / therapy
-
Respiratory Insufficiency / etiology
-
Respiratory Insufficiency / therapy
-
Sepsis / diagnosis
-
Sepsis / drug therapy*
-
Sepsis / etiology
-
Sepsis / microbiology
Substances
-
Anti-Infective Agents
-
Anticoagulants
-
Antineoplastic Agents